Biotricity stock.

16 November 2023 at 9:45 am · 12-min read. Biotricity, Inc. (NASDAQ: BTCY) Q2 2024 Earnings Call Transcript November 14, 2023. Operator: Good afternoon, and welcome to Biotricity's Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today's conference is being recorded. And at this time, I would like to turn the ...Comparatively, Biotricity has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Summary SeaStar Medical and Biotricity tied by winning 7 of the 14 factors compared between the two stocks.How can I reach the investor relations department? For more information, please feel free to reach out to: Biotricity Investor Relations. 1.800.590.4155. [email protected]. KCSA Strategic Communications. Valter Pinto or Jack Perkins. [email protected]. 1-212-896-1254.Biotricity had revenue of $11.11M in the twelve months ending September 30, 2023, with 30.50% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $2.89M with 21.41% year-over-year growth. In the fiscal year ending March 31, 2023, Biotricity had annual revenue of $9.64M with 26.00% growth. Revenue (ttm)

Biotricity, Inc. Common Stock (BTCY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Biotricity Stocks News provide awareness to medical diagnostic and user health care technology which is totally dedicated to delivering innovative, biometric remote moni... stockmarkettodaylive stockstowatchtodayConsumer healthcare technology company Biotricity ( NASDAQ: BTCY) said on Tuesday that its April annualized revenue run rate reached $13M, compared to the $12M run rate for March. The company ...

BTCY : 2.01 (-6.51%) Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022 AccessWire - Tue Mar 8, 2022. Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ ...Get Biotricity Inc (BTCY.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsBiotricity Stock Forecast. Is Biotricity Stock Undervalued? The current Biotricity [ BTCY] share price is $2.13. The Score for BTCY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. BTCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.See Biotricity, Inc. (BTCY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X (Expanded) Industry. There are 17 Sectors, 60 different M Industries ...

Find the latest Biotricity, Inc. (BTCY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components.Nov 21, 2022 · Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it has surpassed $10 million in annual revenue run rate. Biotricity disclaims any representation made, whether explicitly or implicitly, which would suggest the accuracy of the data obtained is suitable for clinical interpretation. Bioheart and its accessories could suffer from interference from external electrical sources. Individuals with a pacemaker or other internal electronic devices within ...BTCY - Biotricity Inc - Stock screener for investors and traders, financial visualizations.Biotricity, Inc. 0.9307. -0.0193. -2.03%. Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, provided a recap of its ...The Biotricity Inc stock price gained 17.25% on the last trading day (Wednesday, 29th Nov 2023), rising from $0.81 to $0.95. During the last trading day the stock fluctuated 19.14% from a day low at $0.81 to a day high of $0.97. The price has been going up and down for this period, and there has been a 5.57% gain for the last 2 weeks.Biotricity to Implement 1-for-6 Reverse Stock Split Jun. 30: MT Transcript : Biotricity, Inc., 2023 Earnings Call, Jun 30, 2023 Jun. 30: CI Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 Jun. 29: CI Biotricity, Inc. Auditor Raises 'Going Concern' Doubt ...

Biotricity Price to Earning is currently at (6.70) X. Price to Earnings ratio is typically used for current valuation of Biotricity and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when Biotricity's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower …... shares of the company on the stock market. Some of the key institutional investors who own shares of Biotricity, Inc. (BTCY) include Vanguard Group ...REDWOOD CITY, CA / ACCESSWIRE / November 14, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor ...Biotricity, Inc. 1.0000. +0.0171. +1.74%. Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has signed an ...Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th AccessWire - Mon May 23, 2022 . REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present and... Biotricity, Inc. ( NASDAQ:BTCY ) shareholders might understandably be very concerned that the share price has dropped...

Current $0.89 Target 349.4%$4.00 Biotricity Stock Rating What analysts recommend for BTCY stock, on a scale from 1 (buy) to 5 (sell). Hold Strong Buy 0% Buy 0% Hold 100% …

Nov 24, 2023 · What is Biotricity's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for Biotricity stock is Buy based on the current 1 buy rating for BTCY. The average twelve-month price prediction for Biotricity is $12.00 with a high price target of $12.00 and a low price target of $12.00. peepo/E+ via Getty Images. Shares of Biotricity ( NASDAQ: BTCY) have been on fire since I re-introduced the Seeking Alpha community to the company in my February 2021 article. Shares reached a 52 ...Find the latest Biotricity, Inc. (BTCY) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Performance. Shares of Biotricity were trading at $0.889 as of November 10. Over the last 52-week period, shares are down 85.54%. Given that these returns are generally negative, long-term ...Biotricity Inc stock performance at a glance. Check Biotricity Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Biotricity Holdings, Inc. ("Biotricity" or the "Company") (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today it will effect a reverse stock split of its common ...Biotricity (NASDAQ:BTCY) said it surpassed $10M in annual revenue run rate. The company added that it delivered revenue growth in 9 out of the last 10 consecutive quarters. Last week, Biotricity reported its FQ2 results, which had missed analysts estimates, despite revenue rising about 32% Y/Y. "I am committed to continuing to drive …Since August, Biotricity has completed a financing to support sales expansion while minimizing dilution and maximizing shareholder value, listed on the Nasdaq exchange, and unveiled the expansion ...About Biotricity Inc. ... stock volatility and illiquidity, and the Company's failure to implement the Company's business plans or strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC. There cannot be any assurance that the Company will ever become profitable.

Biotricity Inc (BTCY) has experienced a 4.40% rise in stock performance for the past week, with a -15.18% drop in the past month, and a -53.88% drop in the past quarter. The volatility ratio for the week is 12.09%, and the volatility levels for the past 30 days are at 13.72% for BTCY.

Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript. Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, and welcome to Biotricity’s Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today’s conference is being recorded.

Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 17,217 Shares Outstanding, K 8,566 Annual …Get the latest Biotricity Inc (BTCY) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q1 2024 ended 6/30/23. Comparatively, Biotricity has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Summary SeaStar Medical and Biotricity tied by winning 7 of the 14 factors compared between the two stocks.Biotricity Inc stock price (BTCY) NASDAQ: BTCY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Biotricity Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Biotricity’s RPM device platform aligns with telemedicine and can be integrated with telehealth solutions. Its flagship product, the Bioflux solution, is a remote patient monitoring device that assists in the diagnosis of heart conditions. ... results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure ...Find the latest Biotricity, Inc. (BTCY) stock quote, history, news and other vital information to help you with your stock trading and investing. October 10, 2023 at 8:15 AM · 5 min read. Biotricity, Inc. REDWOOD CITY, CA / ACCESSWIRE / October 10, 2023 / Biotricity, Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in ...Biotricity Stock Earnings. The value each BTCY share was expected to gain vs. the value that each BTCY share actually gained. Biotricity ( BTCY) reported Q2 2023 earnings per share (EPS) of -$0.41, meeting estimates of -$0.41 by 0.37%. In the same quarter last year, Biotricity 's earnings per share (EPS) was -$0.59.2. 1. #BTCY Target : $3.60 - 3.80 uPto 22% Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic ...16 November 2023 at 9:45 am · 12-min read. Biotricity, Inc. (NASDAQ: BTCY) Q2 2024 Earnings Call Transcript November 14, 2023. Operator: Good afternoon, and welcome to Biotricity's Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today's conference is being recorded. And at this time, I would like to turn the ...Biotricity Trade and Non Trade Payables is fairly stable at the moment as compared to the past year. Biotricity reported Trade and Non Trade Payables of 1.32 Million in 2021. ... Stock Biotricity. Summary; Performance; Fundamentals; Technicals; Advice; Statements Indicators Trends Premiums Profitability Ownership Competition. BTCY - USA Stock ...

Nov 22, 2023 · Biotricity Stock Down 4.2 %. Shares of BTCY opened at $0.91 on Monday. The company has a market cap of $7.80 million, a P/E ratio of -0.57 and a beta of 2.34. Biotricity has a one year low of $0.70 and a one year high of $7.44. The stock has a fifty day moving average price of $1.69. Biotricity Inc (BTCY) has experienced a 4.40% rise in stock performance for the past week, with a -15.18% drop in the past month, and a -53.88% drop in the past quarter. The volatility ratio for the week is 12.09%, and the volatility levels for the past 30 days are at 13.72% for BTCY.Biotricity Accumulated Other Comprehensive Income is fairly stable at the moment as compared to the past year. Biotricity reported Accumulated Other Comprehensive Income of (264,577) in 2021. Analyze Biotricity Accumulated Other Comprehensive Income.Mar 15, 2023 · Biotricity ( NASDAQ: BTCY) is a remote health monitoring company specializing in heart monitoring with a big market in front of it. It has produced its own products, leveraging its core technology ... Instagram:https://instagram. ferrari 4 doorbyd stocblinkcharging stockstockmarket holiday Biotricity (NASDAQ:BTCY) said it surpassed $10M in annual revenue run rate. The company added that it delivered revenue growth in 9 out of the last 10 consecutive quarters. Last week, Biotricity reported its FQ2 results, which had missed analysts estimates, despite revenue rising about 32% Y/Y. "I am committed to continuing to drive … trading forex on td ameritradefutures trading recommendations Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Common Stock, par value $0.001 per share BTCY The NASDAQ Stock Market LLC Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 8,768,650 shares of Common Stock, $0.001 par value, at November 13, 2023. As at that same date, the Company also has 244,453 Exchangeable best bank to refinance investment property / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its ...REDWOOD CITY, CA/ ACCESSWIRE/ September 13, 2023/ Biotricity Inc., a leading medical diagnostic and consumer healthcare technology company, announced today the official launch a new digital ...